Cargando…

CAR-T cells: Early successes in blood cancer and challenges in solid tumors

New approaches to cancer immunotherapy have been developed, showing the ability to harness the immune system to treat and eliminate cancer. For many solid tumors, therapy with checkpoint inhibitors has shown promise. For hematologic malignancies, adoptive and engineered cell therapies are being wide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dana, Hassan, Chalbatani, Ghanbar Mahmoodi, Jalali, Seyed Amir, Mirzaei, Hamid Reza, Grupp, Stephan A., Suarez, Eloah Rabello, Rapôso, Catarina, Webster, Thomas J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144892/ https://www.ncbi.nlm.nih.gov/pubmed/34094824 http://dx.doi.org/10.1016/j.apsb.2020.10.020

Ejemplares similares

The Hippo Tumor Suppressor Pathway (YAP/TAZ/TEAD/MST/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

Chimeric Antigen Receptor (CAR) T Cell Therapy for Metastatic Melanoma: Challenges and Road Ahead
por: Soltantoyeh, Tahereh, et al.
Publicado: (2021)

Encapsulated Checkpoint Blocker Before Chemotherapy: The Optimal Sequence of Anti-CTLA-4 and Doxil Combination Therapy
por: Alimohammadi, Reza, et al.
Publicado: (2020)

The Role and Function of Ras-association domain family in Cancer: A Review
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2019)

The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases
por: Zinatizadeh, Mohammad Reza, et al.
Publicado: (2020)

Roadblocks to success for RNA CARs in solid tumors
por: Singh, Nathan, et al.
Publicado: (2015)

Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy
por: de Campos, Najla Santos Pacheco, et al.
Publicado: (2022)

Dual blockage of both PD-L1 and CD47 enhances the therapeutic effect of oxaliplatin and FOLFOX in CT-26 mice tumor model
por: Alimohammadi, Reza, et al.
Publicado: (2023)

Combining ablative radiotherapy and anti CD47 monoclonal antibody improves infiltration of immune cells in tumor microenvironments
por: Rostami, Elham, et al.
Publicado: (2022)

In silico Analysis, Molecular Docking, Molecular Dynamic, Cloning, Expression and Purification of Chimeric Protein in Colorectal Cancer Treatment
por: Dana, Hassan, et al.
Publicado: (2020)

Integrative and in-vitro analysis reveal hsa_circ_001787 can act as a diagnostic biomarker for colorectal cancer
por: Chalbatani, Ghanbar Mahmoodi, et al.
Publicado: (2021)

Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2019)

A New World of Biomarkers and Therapeutics for Female Reproductive System and Breast Cancers: Circular RNAs
por: Tran, Anh M., et al.
Publicado: (2020)

Genetic Modification of Cytokine Signaling to Enhance Efficacy of CAR T Cell Therapy in Solid Tumors
por: Ghahri-Saremi, Navid, et al.
Publicado: (2021)

Molecular Mechanisms and Biological Functions of siRNA
por: Dana, Hassan, et al.
Publicado: (2017)

The integrative multi-omics approach identifies the novel competing endogenous RNA (ceRNA) network in colorectal cancer
por: Mahmoodi Chalbatani, Ghanbar, et al.
Publicado: (2023)

Isolated Peptide from Spider Venom Modulates Dendritic Cells In Vitro: A Possible Application in Oncoimmunotherapy for Glioblastoma
por: de Mato, Felipe Cezar, et al.
Publicado: (2023)

Outsmarting trogocytosis to boost CAR NK/T cell therapy
por: Ramezani, Faezeh, et al.
Publicado: (2023)

Biological function and molecular mechanism of piRNA in cancer
por: Chalbatani, Ghanbar Mahmoodi, et al.
Publicado: (2018)

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, David, et al.
Publicado: (2018)

Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
por: Masoumi, Javad, et al.
Publicado: (2021)

Crosstalk between autophagy and metabolic regulation of (CAR) T cells: therapeutic implications
por: Panahi Meymandi, Ahmad Reza, et al.
Publicado: (2023)

Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield
por: Jo, Yuna, et al.
Publicado: (2020)

Seventeen Alpha-Hydroxylase Deficiency Associated with Absent Gonads and Myelolipoma: A Case Report and Review of Literature
por: Soveid, Mahmood, et al.
Publicado: (2016)

Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
por: Jafarzadeh, Leila, et al.
Publicado: (2020)

Evaluation of Solid Particle Number Sensors for Periodic Technical Inspection of Passenger Cars
por: Melas, Anastasios, et al.
Publicado: (2021)

S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)

Making CAR T Cells a Solid Option for Solid Tumors
por: Schmidts, Andrea, et al.
Publicado: (2018)

Characterization of Leukemic Resistance to CD19-Targeted CAR T-cell Therapy through Deep Genomic Sequencing
por: Chen, Gregory M., et al.
Publicado: (2023)

Correction to: Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, D., et al.
Publicado: (2018)

CAR T cells in solid tumors: challenges and opportunities
por: Marofi, Faroogh, et al.
Publicado: (2021)

CAR-NK Cells in the Treatment of Solid Tumors
por: Wrona, Ewa, et al.
Publicado: (2021)

CAR T Cell Locomotion in Solid Tumor Microenvironment
por: Nguyen, Duy T., et al.
Publicado: (2022)

CAR-T Therapies in Solid Tumors: Opportunities and Challenges
por: Guzman, Grace, et al.
Publicado: (2023)

CAR T-Cell Therapy in Children with Solid Tumors
por: Kulczycka, Marika, et al.
Publicado: (2023)

Highly Efficient Generation of Transgenically Augmented CAR NK Cells Overexpressing CXCR4
por: Jamali, Arezoo, et al.
Publicado: (2020)

PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer
por: Akbari, Behnia, et al.
Publicado: (2023)

Universal redirection of CAR T cells against solid tumours via membrane-inserted ligands for the CAR
por: Zhang, Angela Q., et al.
Publicado: (2023)

Genetic and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cells
por: Masoumi, Elham, et al.
Publicado: (2020)

New Strategies for the Treatment of Solid Tumors with CAR-T Cells
por: Zhang, Hao, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3i5vd99jkomjspo1tfsu72d52t